{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:57:57Z","timestamp":1778810277183,"version":"3.51.4"},"reference-count":42,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background\/Objectives: The hypothalamic-pituitary-testis axis is known to be dysregulated in patients with hematological malignancies. However, data on the association between the type of hematological malignancies and semen quality are discordant. In the era of personalized medicine, identifying disease-specific patterns of reproductive impairment is crucial to optimize fertility preservation strategies. While patients with leukemia often show a clear deterioration in semen quality, studies on Hodgkin and non-Hodgkin lymphomas have shown that spermatogenesis is not always compromised. Indeed, some patients may present normospermia before treatment. This study aimed to assess semen parameters in males affected by hematological malignancies compared with a non-cancer population and to explore implications for individualized fertility preservation counseling. Methods: We performed a retrospective monocentric study including all patients affected by hematological malignancies who underwent fertility preservation at the Maternal and Child Department, Gynecology and Obstetrics, Oncofertility Unit, Federico II of Naples, from January 2017 through December 2024. In total, 247 patients with hematological malignancies and 63 non-cancer males undergoing in vitro fertilization for female tubal factor, selected as a control group, were included in the analysis. Sperm parameters (semen volume, sperm concentration, motility, and morphology) were first compared between the hematological malignancy group and the control group, and then among hematological malignancies classified as Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), and leukemia (L). Results: Overall, according to World Health Organization (WHO, 2021) criteria, semen parameters of patients with hematological malignancies were at the 25th percentile, except for motility, which was below the 5th percentile. Significant differences were observed in sperm concentration\/mL, total sperm number, and percentage of total sperm motility between the hematological malignancy group and the control group (p = 0.0004; p = 0.0003; p &lt; 0.0001). Based on disease classification, 158 patients had Hodgkin lymphoma, 54 had non-Hodgkin lymphoma, and 35 had leukemia. Significant differences in concentration\/mL and total sperm number were found between the Hodgkin lymphoma group and the control group (p = 0.003; p = 0.001). The percentage of total sperm motility was significantly decreased in all subtypes of hematological malignancies compared with controls, especially in the leukemia group (HL p = 0.001; NHL p = 0.004; L p &lt; 0.001). Conclusions: These findings highlight significant impairment of semen quality, particularly motility, reinforcing the role of personalized medicine in tailoring fertility preservation strategies according to malignancy subtype and baseline reproductive risk.<\/jats:p>","DOI":"10.3390\/jpm16010011","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:08:00Z","timestamp":1767197280000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Semen Quality in Patients with Hematological Malignancies: A Retrospective Monocentric Study in the Perspective of Personalized Oncofertility Medicine"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2495-860X","authenticated-orcid":false,"given":"Federica","family":"Cariati","sequence":"first","affiliation":[{"name":"Department of Public Health, School of Medicine, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Orsi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Capasso","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Universitaria Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Pagano","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Universitaria Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bagnulo","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Universitaria Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele Giuseppe","family":"Iorio","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9311-0617","authenticated-orcid":false,"given":"Maria Giuseppina","family":"Trinchillo","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Medicine, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Ordichelli","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Medicine, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6554-0874","authenticated-orcid":false,"given":"Maurizio","family":"Guido","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Unit, Annunziata Hospital, Via Migliori 1, 87100 Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Estrusco","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Childcare, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Alviggi","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Medicine, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-0055","authenticated-orcid":false,"given":"Alessandro","family":"Conforti","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Universitaria Federico II, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40364-025-00775-1","article-title":"Targeting Myeloid Cells for Hematological Malignancies: The Present and Future","volume":"13","author":"Guan","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Karagianni, P., Giannouli, S., and Voulgarelis, M. (2021). From the (Epi)Genome to Metabolism and Vice Versa; Examples from Hematologic Malignancy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126321"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2018.07.003","article-title":"Evolution of Survivorship in Lymphoma, Myeloma and Leukemia: Metamorphosis of the Field into Long Term Follow-up Care","volume":"33","author":"Damlaj","year":"2019","journal-title":"Blood Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A Revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"ref_5","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., and Thiele, J. (2017). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global Burden of Hematologic Malignancies and Evolution Patterns over the Past 30 Years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/17474086.2025.2558710","article-title":"Global, Regional, and National Burden of Hodgkin Lymphoma, 1990\u20132021, and Predictions for 2050: An Analysis of the Global Burden of Disease Study 2021","volume":"18","author":"Li","year":"2025","journal-title":"Expert Rev. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin\u2019s Lymphoma After Infectious Mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnci\/djr516","article-title":"Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups","volume":"104","author":"Urayama","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","unstructured":"PDQ Pediatric Treatment Editorial Board (2002). Childhood Hodgkin Lymphoma Treatment (PDQ\u00ae): Health Professional Version, PDQ Cancer Information Summaries."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Shrem, G., Azani, L., Feferkorn, I., Listovsky, T., Hussaini, S., Farber, B., Dahan, M.H., and Salmon-Divon, M. (2022). Effect of Malignancy on Semen Parameters. Life, 12.","DOI":"10.3390\/life12060922"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e13794","DOI":"10.1111\/and.13794","article-title":"Parameters Associated with Sperm Quality Prior to Chemotherapy in Lymphoma Patients","volume":"52","author":"Karavani","year":"2020","journal-title":"Andrologia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/humrep\/15.9.1985","article-title":"Follow-up of Sperm Concentration and Motility in Patients with Lymphoma","volume":"15","author":"Tal","year":"2000","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/humrep\/deg163","article-title":"Testicular Cancer and Hodgkin\u2019s Disease: Evaluation of Semen Quality","volume":"18","author":"Gandini","year":"2003","journal-title":"Hum. Reprod."},{"key":"ref_15","first-page":"263","article-title":"Spermatogenesis in Hodgkin\u2019s Lymphoma Patients: A Retrospective Study of Semen Quality before and after Different Chemotherapy Regimens","volume":"31","author":"Paoli","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_16","first-page":"16","article-title":"Semen Quality in Non-Hodgkin Lymphoma Survivors: A Monocentric Retrospective Study","volume":"36","author":"Pallotti","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/andr.13087","article-title":"Association of Malignant Neoplasms with Semen Quality in Guangdong Province, China: A Propensity Score Matching Analysis","volume":"10","author":"Fan","year":"2022","journal-title":"Andrology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.fertnstert.2008.03.053","article-title":"Survival and Infertility Treatment in Male Cancer Patients after Sperm Banking","volume":"91","author":"Crha","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO-24-02782","article-title":"Fertility Preservation in People with Cancer: ASCO Guideline Update","volume":"43","author":"Su","year":"2025","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Peluso, G., Tisato, V., Singh, A.V., Gemmati, D., and Scarpellini, F. (2023). Semen Cryopreservation to Expand Male Fertility in Cancer Patients: Intracase Evaluation of Semen Quality. J. Pers. Med., 13.","DOI":"10.3390\/jpm13121654"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"30072","DOI":"10.1038\/s41598-025-15456-0","article-title":"Impact of Cryopreservation Agents on Sperm Quality, DNA Fragmentation, and Apoptotic Markers in Fertile and Infertile Males","volume":"15","author":"Abdraboh","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1758834016665078","article-title":"Fertility Preservation in Males with Cancer: 16-Year Monocentric Experience of Sperm Banking and Post-Thaw Reproductive Outcomes","volume":"8","author":"Depalo","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1007\/s00432-022-04488-y","article-title":"Sperm and Testicular Tissue Cryopreservation and Assisted Reproductive Technology Outcomes in Male Cancer Patients: A 15-Year Experience","volume":"149","author":"Stelzer","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10147-011-0330-3","article-title":"Sperm Banking and Assisted Reproductive Outcome in Men with Cancer: A 10 Years\u2019 Experience","volume":"17","author":"Freour","year":"2012","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_25","unstructured":"World Health Organization (2021). WHO Laboratory Manual for the Examination and Processing of Human Semen, World Health Organization. [6th ed.]. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240030787."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/humrep\/12.1.73","article-title":"Sperm Quality in Hodgkin\u2019s Disease versus Non-Hodgkin\u2019s Lymphoma","volume":"12","author":"Botchan","year":"1997","journal-title":"Hum. Reprod."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/and.12451","article-title":"Do Malignant Diseases Affect Semen Quality? Sperm Parameters of Men with Cancers","volume":"48","author":"Caponecchia","year":"2016","journal-title":"Andrologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4111\/icu.20220402","article-title":"Semen Quality and Sperm DNA Fragmentation in Cancer Patients Undergoing Sperm Cryopreservation","volume":"64","author":"Song","year":"2023","journal-title":"Investig. Clin. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Calamai, C., Ammar, O., Rosta, V., Farnetani, G., Zimmitti, S., Giovannelli, L., Vignozzi, L., Krausz, C., and Muratori, M. (2023). Testicular and Haematological Cancer Induce Very High Levels of Sperm Oxidative Stress. Antioxidants, 12.","DOI":"10.3390\/antiox12061145"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s43032-020-00408-y","article-title":"Current Insights and Latest Updates in Sperm Motility and Associated Applications in Assisted Reproduction","volume":"29","author":"Dcunha","year":"2022","journal-title":"Reprod. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1007\/s00277-025-06426-7","article-title":"Semen Quality in Acute Leukemia Patients: A Retrospective Study","volume":"104","author":"Buonacquisto","year":"2025","journal-title":"Ann. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3324\/haematol.2009.009696","article-title":"Sperm Quality before Treatment in Patients with Early Stage Hodgkin\u2019s Lymphoma Enrolled in EORTC-GELA Lymphoma Group Trials","volume":"94","author":"Heutte","year":"2009","journal-title":"Haematologica"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Caserta, S., Cancemi, G., Murdaca, G., Stagno, F., Di Gioacchino, M., Gangemi, S., and Allegra, A. (2024). The Effects of Cancer Immunotherapy on Fertility: Focus on Hematological Malignancies. Biomedicines, 12.","DOI":"10.3390\/biomedicines12092106"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13148-022-01417-1","article-title":"Sperm DNA Methylome Abnormalities Occur Both Pre- and Post-Treatment in Men with Hodgkin Disease and Testicular Cancer","volume":"15","author":"Chan","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Calamai, C., Chelli, E., Ammar, O., Tanturli, M., Vignozzi, L., and Muratori, M. (2024). Reliable Detection of Excessive Sperm Ros Production in Subfertile Patients: How Many Men with Oxidative Stress?. Antioxidants, 13.","DOI":"10.3390\/antiox13091123"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmp047","article-title":"The Impact of Body Mass Index on Semen Parameters and Reproductive Hormones in Human Males: A Systematic Review with Meta-Analysis","volume":"16","author":"MacDonald","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"ref_37","first-page":"247","article-title":"Male Reproductive Health-Study of a Sperm Donor Population","volume":"26","author":"Fonseca","year":"2022","journal-title":"JBRA Assist. Reprod."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Neto, F.T.L., Viana, M.C., Cariati, F., Conforti, A., Alviggi, C., and Esteves, S.C. (2024). Effect of Environmental Factors on Seminal Microbiome and Impact on Sperm Quality. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1348186"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"deae108.334","DOI":"10.1093\/humrep\/deae108.334","article-title":"P-006 Fertility Outcomes in Men Diagnosed with Oncohematological Diseases Who Stored Their Semen for Fertility Preservation","volume":"39","author":"Reschini","year":"2024","journal-title":"Hum. Reprod."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Cariati, F., Orsi, M.G., Bagnulo, F., Del Mondo, D., Vigilante, L., De Rosa, M., Sciorio, R., Conforti, A., Fleming, S., and Alviggi, C. (2024). Advanced Sperm Selection Techniques for Assisted Reproduction. J. Pers. Med., 14.","DOI":"10.3390\/jpm14070726"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1200\/OP-24-00888","article-title":"Natural and Assisted Conceptions in Male Patients with Blood Cancers Who Stored Their Semen for Fertility Preservation","volume":"21","author":"Reschini","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11764-014-0398-7","article-title":"Assisted reproductive outcomes of male cancer survivors","volume":"9","author":"Herrero","year":"2015","journal-title":"J Cancer Surviv."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T08:52:12Z","timestamp":1767603132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jpm16010011"],"URL":"https:\/\/doi.org\/10.3390\/jpm16010011","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}